These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14313750)

  • 1. EVIDENCE OF A NORMALLY FUNCTIONING PITUITARY TSH SECRETION MECHANISM IN A PATIENT WITH A HIGH BLOOD LEVEL OF LONG-ACTING THYROID STIMULATOR.
    ADAMS DD; KENNEDY TH
    J Clin Endocrinol Metab; 1965 May; 25():571-6. PubMed ID: 14313750
    [No Abstract]   [Full Text] [Related]  

  • 2. THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE.
    PINCHERA A; PINCHERA MG; STANBURY JB
    J Clin Endocrinol Metab; 1965 Feb; 25():189-208. PubMed ID: 14264241
    [No Abstract]   [Full Text] [Related]  

  • 3. IMMUNOLOGICAL STUDIES ON THE LONG-ACTING THYROID STIMULATOR.
    DORRINGTON KJ; MUNRO DS
    Clin Sci; 1965 Feb; 28():165-74. PubMed ID: 14256898
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of iodine administration on the thyrotropic hormone and long-acting thyroid stimulator level in the plasma].
    Földes J; Krasznai I; Piroska E; Gesztesi E; Takács I
    Endokrinologie; 1967; 52(1):80-7. PubMed ID: 4171706
    [No Abstract]   [Full Text] [Related]  

  • 5. The nature and significance of the long-acting thyroid stimulator.
    Kriss J
    Adv Metab Disord; 1968; 3():209-30. PubMed ID: 4178338
    [No Abstract]   [Full Text] [Related]  

  • 6. PRESENCE OF THE LONG-ACTING THYROID STIMULATOR IN SERUM IN MONGOLISM WITHOUT HYPERTHYROIDISM.
    MOSIER HD
    J Clin Endocrinol Metab; 1965 Aug; 25():1005-8. PubMed ID: 14328369
    [No Abstract]   [Full Text] [Related]  

  • 7. THE EFFECT OF THYROID HORMONE ON THE LEVELS OF THYROTROPIN (TSH) AND LONG-ACTING THYROID STIMULATOR (L.A.T.S.) IN THYROID DISORDERS.
    SAKAGAMI A; FUKUCHI M; MASUI H; MIYAI K; IWATSUBO H; KUMAHARA Y; YOSHIDA T
    Med J Osaka Univ; 1964 Mar; 14():235-44. PubMed ID: 14195720
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the treatment of hyperthyroidism with Iodine-131.
    Torizuka K; Mori T; Konishi J; Morita R; Hamamoto K; Kusakabe T; Miyake T; Fukase M
    J Nucl Med; 1967 May; 8(5):335. PubMed ID: 6032620
    [No Abstract]   [Full Text] [Related]  

  • 9. ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA.
    KRISS JP; PLESHAKOV V; CHIEN JR
    J Clin Endocrinol Metab; 1964 Oct; 24():1005-28. PubMed ID: 14228525
    [No Abstract]   [Full Text] [Related]  

  • 10. [EFFECT OF THE ADMINISTRATION OF THE THYROID HORMONE ON THE LEVELS OF TSH AND LATS IN THE SERUM OF THE THYROID PATIENTS].
    SAKAGAMI A
    Nihon Naika Gakkai Zasshi; 1964 Feb; 52():1317-22. PubMed ID: 14156206
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of LATS and TSH in the blood.
    Lemarchand-Béraud T; Griessen M; Scazziga BR
    Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
    [No Abstract]   [Full Text] [Related]  

  • 12. Positive correlation of the long-acting thyroid stimulator (LATS) with the percentage of endogenously labelled 131 I triiodothyronine in the plasma of hyperthyroid patients.
    Emrich D; Albani M; zur Mühlen A von
    Acta Endocrinol (Copenh); 1971 Nov; 68(3):445-50. PubMed ID: 4107957
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroid suppression and the long-acting thyroid stimulator following radioactive iodine therapy for thyrotoxicosis.
    Alford FP; Larkins RG; Martin FI
    Aust N Z J Med; 1971 Nov; 1(4):339-45. PubMed ID: 5292990
    [No Abstract]   [Full Text] [Related]  

  • 14. The interaction between thyroid tissue and the long-acting thyroid stimulator.
    Kendall-Taylor P; Smith BR; Munro DS
    Q J Med; 1971 Oct; 40(160):564-5. PubMed ID: 4110160
    [No Abstract]   [Full Text] [Related]  

  • 15. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
    zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
    Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
    [No Abstract]   [Full Text] [Related]  

  • 16. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
    [No Abstract]   [Full Text] [Related]  

  • 17. CLINICAL STUDIES ON THE LONG-ACTING THYROID STIMULATOR.
    NOGUCHI A; KURIHARA H; SATO S
    J Clin Endocrinol Metab; 1964 Feb; 24():160-5. PubMed ID: 14123839
    [No Abstract]   [Full Text] [Related]  

  • 18. THE METABOLISM OF BIOLOGICALLY IMPORTANT RADIONUCLIDES. V. THE METABOLISM OF RADIOIODINE AND RADIATION DOSAGE IN MAN.
    HALNAN KE
    Br J Radiol; 1964 Feb; 37():101-7. PubMed ID: 14120786
    [No Abstract]   [Full Text] [Related]  

  • 19. [SUPPLEMENTARY ISOTOPE TESTS WITH RADIOACTIVE IODINE (I-131) IN THE DIAGNOSIS AND THERAPY OF THYROID DISEASES].
    GASIOROWSKI W
    Pol Tyg Lek; 1963 Aug; 18():1209-14. PubMed ID: 14087952
    [No Abstract]   [Full Text] [Related]  

  • 20. CLINICAL AND RADIOBIOLOGICAL OBSERVATIONS ON LATENT EFFCTS OF X-IRRADIATION ON THE THYROID GLAND.
    GREIG WR; BOYLE JA; BUCHANAN WW; FULTON S
    J Clin Endocrinol Metab; 1965 Aug; 25():1009-14. PubMed ID: 14328370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.